These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 11532902)

  • 1. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
    Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A
    Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
    Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
    Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiinflammatory and antiarteriosclerotic effects of pioglitazone.
    Ishibashi M; Egashira K; Hiasa K; Inoue S; Ni W; Zhao Q; Usui M; Kitamoto S; Ichiki T; Takeshita A
    Hypertension; 2002 Nov; 40(5):687-93. PubMed ID: 12411463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions.
    Egashira K; Ni W; Inoue S; Kataoka C; Kitamoto S; Koyanagi M; Takeshita A
    Hypertens Res; 2000 Jul; 23(4):353-8. PubMed ID: 10912772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis.
    Zhao Q; Egashira K; Inoue S; Usui M; Kitamoto S; Ni W; Ishibashi M; Hiasa Ki K; Ichiki T; Shibuya M; Takeshita A
    Circulation; 2002 Mar; 105(9):1110-5. PubMed ID: 11877364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis.
    Koyanagi M; Egashira K; Kitamoto S; Ni W; Shimokawa H; Takeya M; Yoshimura T; Takeshita A
    Circulation; 2000 Oct; 102(18):2243-8. PubMed ID: 11056100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis.
    Lecian D; Demova H; Lodererova A; Zdychova J; Kluckova H; Teplan V; Voska L; Komers R
    Kidney Blood Press Res; 2006; 29(3):135-43. PubMed ID: 16899993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis.
    Kataoka C; Egashira K; Ishibashi M; Inoue S; Ni W; Hiasa K; Kitamoto S; Usui M; Takeshita A
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H768-74. PubMed ID: 14592942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
    Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
    Martínez-González J; Alfón J; Berrozpe M; Badimon L
    Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC.
    Takeuchi S; Kawashima S; Rikitake Y; Ueyama T; Inoue N; Hirata K; Yokoyama M
    Biochem Biophys Res Commun; 2000 Mar; 269(1):97-102. PubMed ID: 10694484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats.
    Kitamoto S; Egashira K; Kataoka C; Koyanagi M; Katoh M; Shimokawa H; Morishita R; Kaneda Y; Sueishi K; Takeshita A
    Circulation; 2000 Aug; 102(7):806-12. PubMed ID: 10942751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels.
    Tomita H; Egashira K; Kubo-Inoue M; Usui M; Koyanagi M; Shimokawa H; Takeya M; Yoshimura T; Takeshita A
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1456-64. PubMed ID: 9743235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
    Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S
    Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
    Alfon J; Guasch JF; Berrozpe M; Badimon L
    Atherosclerosis; 1999 Aug; 145(2):325-31. PubMed ID: 10488960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
    Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
    Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.